Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Parente, Daniella Braz ^a,b   Rodrigues, Rosana Souza ^a,b   Paiva, Ferno Fernes ^a,d   Neto, Jaime Araújo Oliveira ^a   Machado Silva, Lilian ^c   Lanzoni, Valeria ^e   Campos, Carlos Frederico Ferreira ^c   Eiras Araujo, Antonio Luis ^a,b   Americano Do Brasil, Pedro Emmanuel Alvarenga ^a   Garteiser, Philippe ^f   De Brito Gomes, Marilia ^c   De Mello Perez, Renata ^a,b,c  

^a D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e Federal University of Saandtild O Paulo Saandtild O Paulo   (United States)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; HEPATOGRAPHY; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREVALENCE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; BIOPSY; COMPLICATION; DIABETES MELLITUS, TYPE 2; LIVER; MIDDLE AGED; PATHOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX;

BIOPSY; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84913568899     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112574     Document Type: Article

References (47)

1. Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43: S99-S112.
2. Ong JP, Younossi ZM (2007) Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 11: 1-16, vii.
3. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, et al. (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288: E462-468.
4. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231.
5. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395.
6. Brunt EM, Tiniakos DG (2010) Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 16: 5286-5296.
7. Tiniakos DG, Vos MB, Brunt EM (2010) Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 5: 145-171.
8. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, et al. (2011) Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 141: 1249-1253.
9. Leite NC, Salles GF, Araujo AL, Villela-Nogueira CA, Cardoso CR (2009) Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int 29: 113-119.
10. Cusi K (2009) Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 16: 141-149.
11. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, et al. (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140: 124-131.
12. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, et al. (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30: 1212-1218.
13. Loomba R, Abraham M, Unalp A, Wilson L, Lavine J, et al. (2012) Association between diabetes, family history of diabetes and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology.
14. Neuschwander-Tetri BA, Clark JM, Bass NM, Van Natta ML, Unalp-Arida A, et al. (2010) Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 52: 913-924.
15. Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, et al. (1990) Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 85: 1349-1355.
16. Wanless IR, Lentz JS (1990) Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12: 1106-1110.
17. Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA (2008) Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 57: 1441-1447.
18. Lazo M, Clark JM (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28: 339-350.
19. Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, et al. (2004) Nonalcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 19: 854-858.
20. Adams LA, Harmsen S, St Sauver JL, Charatcharoenwitthaya P, Enders FB, et al. (2010) Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol 105: 1567-1573.
21. Ma X, Holalkere NS, Kambadakone RA, Mino-Kenudson M, Hahn PF, et al. (2009) Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 29: 1253-1277.
22. Qayyum A, Chen DM, Breiman RS, Westphalen AC, Yeh BM, et al. (2009) Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging 33: 110-115.
23. Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging 34: spcone.
24. Strauss S, Gavish E, Gottlieb P, Katsnelson L (2007) Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 189: W320-323.
25. Pickhardt PJ, Jee Y, O'Connor SD, del Rio AM (2012) Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome. AJR Am J Roentgenol 198: 1100-1107.
26. Cassidy FH, Yokoo T, Aganovic L, Hanna RF, Bydder M, et al. (2009) Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 29: 231-260.
27. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, et al. (2009) Noninvasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 51: 433-445.
28. Reeder SB, Robson PM, Yu H, Shimakawa A, Hines CD, et al. (2009) Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 29: 1332-1339.
29. Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, et al. (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flipangle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251: 67-76.
30. Kuhn JP, Hernando D, Munoz del Rio A, Evert M, Kannengiesser S, et al. (2012) Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 265: 133-142.
31. Stefan D, Di Cesare F, Andrasescu A, Popa E, Lazariev A, et al. (2009) Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package. Measurement Science & Technology 20.
32. Hamilton G, Yokoo T, Bydder M, Cruite I, Schroeder ME, et al. (2011) In vivo characterization of the liver fat (1)H MR spectrum. NMR Biomed 24: 784-790.
33. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321.
34. Obuchowski NA (2006) An ROC-type measure of diagnostic accuracy when the gold standard is continuous-scale. Stat Med 25: 481-493.
35. Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, et al. (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267: 767-775.
36. d'Assignies G, Ruel M, Khiat A, Lepanto L, Chagnon M, et al. (2009) Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods. Eur Radiol 19: 2033-2040.
37. Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, et al. (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display-early experience. Radiology 237: 1048-1055.
38. Tang A, Tan J, Sun M, Hamilton G, Bydder M, et al. (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267: 422-431.
39. van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, et al. (2010) Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 256: 159-168.
40. Kim H, Taksali SE, Dufour S, Befroy D, Goodman TR, et al. (2008) Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL. Magn Reson Med 59: 521-527.
41. Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, et al. (2010) Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 52: 579-585.
42. Noworolski SM, Lam MM, Merriman RB, Ferrell L, Qayyum A (2012) Liver Steatosis: Concordance of MR Imaging and MR Spectroscopic Data with Histologic Grade. Radiology 264: 88-96.
43. Westphalen AC, Qayyum A, Yeh BM, Merriman RB, Lee JA, et al. (2007) Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 242: 450-455.
44. O'Regan DP, Callaghan MF, Wylezinska-Arridge M, Fitzpatrick J, Naoumova RP, et al. (2008) Liver fat content and T2: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T-feasibility. Radiology 247: 550-557.
45. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, et al. (1994) Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12: 487-495.
46. Mashhood A, Railkar R, Yokoo T, Levin Y, Clark L, et al. (2012) Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging. J Magn Reson Imaging.
47. Hamilton G, Middleton MS, Bydder M, Yokoo T, Schwimmer JB, et al. (2009) Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging 30: 145-152.